Abdul Rafeh Naqash: A state of the art review on pulmonary neuroendocrine neoplasms
Abdul Rafeh Naqash, Associate Professor and Director of Clinical Research at UT Southwestern Medical Center, shared a recent article by him and colleagues on X:
“A state-of-the-art review on pulmonary neuroendocrine neoplasms.
Now online at The Lancet Oncology at the start of 2025.
Super honored to have been a part of this effort led by Triparna Sen with others, Sonam Puri, Nagla Abdel Karim, Vineeth Sukrithan, and OU Health Stephenson Cancer Center.”
Authors: Triparna Sen, Yosuke Dotsu, Virginia Corbett, Sonam Puri, Utsav Sen, Theresa A Boyle, Phil Mack, Fred Hirsch, Raid Aljumaily, Abdul Rafeh Naqash, Vineeth Sukrithan and Nagla Abdel Karim
Abdul Rafeh Naqash is an Assistant Professor in the early phase division of the Stephenson Cancer Center at the University of Oklahoma. Dr. Naqash focuses on conducting innovative clinical trials and biomarker-based research. Dr. Naqash has published in high-impact journals and has collaborated widely with researchers worldwide.
More posts featuring Abdul Rafeh Naqash.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023